Crossmark

Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–2017

Crossref DOI link: https://doi.org/10.1186/s12981-020-00328-6

Published Online: 2021-01-09

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Korten, Volkan http://orcid.org/0000-0002-9991-814X
Gökengin, Deniz http://orcid.org/0000-0003-0704-2302
Eren, Gülhan

Yıldırmak, Taner http://orcid.org/0000-0001-7006-7161
Gencer, Serap http://orcid.org/0000-0002-3217-6305
Eraksoy, Haluk http://orcid.org/0000-0002-5790-0806
Inan, Dilara http://orcid.org/0000-0002-7551-6728
Kaptan, Figen

Dokuzoğuz, Başak http://orcid.org/0000-0001-7403-3292
Karaoğlan, Ilkay http://orcid.org/0000-0002-6767-4523
Willke, Ayşe

Gönen, Mehmet http://orcid.org/0000-0002-2483-075X
Ergönül, Önder http://orcid.org/0000-0003-1935-9235
Funding

Funding for this research was provided by:

Gilead Sciences (IN-TR-236-1996)
License Information

Text and Data Mining valid from 2021-01-09

Version of Record valid from 2021-01-09
More Information

Article History

Received: 8 February 2020

Accepted: 14 December 2020

First Online: 9 January 2021

Ethics approval and consent to participate

: The study protocol was approved by the local ethical review board of the Marmara University School of Medicine (15 Jul 2016, No: 09.2016.398). Consent to participate: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below